Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCRC-LC1: Maintenance Chemo vs RT + Maintenance Chemo in MCRC
NCT03142282Phase 2Unknown
- Start
- Jan 2019
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms). Primary endpoint: Progression-Free Survival at 2 years. Status: unknown.
Beyond the preview
Go deeper on NCT03142282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03142282.